Initial treatment of steroid-sensitive idiopathic nephrotic syndrome in children with mycophenolate mofetil versus prednisone: protocol for a randomised, controlled, multicentre trial (INTENT study)
Introduction Idiopathic nephrotic syndrome is the most common glomerular disease in childhood with an incidence of 1.8 cases per 100 000 children in Germany. The treatment of the first episode implies two aspects: induction of remission and sustainment of remission. The recent Kidney Disease Improvi...
Saved in:
Main Authors: | Burkhard Toenshoff, Martin Konrad, Steffen Luntz, Anja Sander, Peter F Hoyer, Rasmus Ehren, Marcus R Benz, Jorg Doetsch, Alexander Fichtner, Jutta Gellermann, Dieter Haffner, Britta Höcker, Bärbel Kästner, Markus J Kemper, Uwe Querfeld, Lutz T Weber |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2018-10-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/8/10/e024882.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mycophenolate Mofetil and Clostridium difficile-associated Colitis
by: A. I. Dolgushina, et al.
Published: (2021-12-01) -
Cyclophosphamide and mycophenolate mofetil as induction therapy in lupus nephritis
by: Božić-Majstorović Ljubinka, et al.
Published: (2024-01-01) -
Mycophenolate mofetil induced transfusion dependent anemia in lupus
by: Anand Prahalad Rao, et al.
Published: (2018-01-01) -
Effect and Safety of Mycophenolate Mofetil in Idiopathic Pulmonary Fibrosis
by: Argyris Tzouvelekis, et al.
Published: (2011-01-01) -
Mycophenolate Mofetil for the Treatment of Autoimmune Hepatitis in Patients Refractory to Standard Therapy
by: Shane M Devlin, et al.
Published: (2004-01-01)